Author:
Murali Mahadevamurthy,Ahmed Faiyaz,Gowtham Hittanahallikoppal Gajendramurthy,Aribisala Jamiu Olaseni,Abdulsalam Rukayat Abiola,Shati Ali A.,Alfaifi Mohammad Y.,Sayyed R. Z.,Sabiu Saheed,Amruthesh Kestur Nagaraj
Abstract
AbstractAn opportunistic human pathogenic bacterium, Chromobacterium violaceum resists the potency of most antibiotics by exploiting the quorum sensing system within their community to control virulence factor expression. Therefore, blocking the quorum sensing mechanism could help to treat several infectious caused by this organism. The quorum sensing receptor (CviR) of C. violaceum was used as a model target in the current investigation to identify potentially novel quorum sensing inhibitors from Cladosporium spp. through in silico computational approaches. The molecular docking results confirmed the anti-quorum sensing potential of bioactive compounds from Cladosporium spp. through binding to CviR with varying docking scores between – 5.2 and – 9.5 kcal/mol. Relative to the positive control [Azithromycin (– 7.4 kcal/mol)], the top six metabolites of Cladosporium spp. had higher docking scores and were generally greater than – 8.5 kcal/mol. The thermodynamic stability and binding affinity refinement of top-ranked CviR inhibitors were further studied through a 160 ns molecular dynamic (MD) simulation. The Post-MD simulation analysis confirmed the top-ranked compounds' affinity, stability, and biomolecular interactions with CviR at 50 ns, 100 ns, and 160 ns with Coniochaetone K of the Cladosporium spp. having the highest binding free energy (– 30.87 kcal/mol) and best interactions (two consistent hydrogen bond contact) following the 160 ns simulation. The predicted pharmacokinetics properties of top selected compounds point to their drug likeliness, potentiating their chance as a possible drug candidate. Overall, the top-ranked compounds from Cladosporium spp., especially Coniochaetone K, could be identified as potential C. violaceum CviR inhibitors. The development of these compounds as broad-spectrum antibacterial medicines is thus possible in the future following the completion of further preclinical and clinical research.
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Alisjahbana, B., Debora, J., Susandi, E. & Darmawan, G. Chromobacterium violaceum: A review of an unexpected scourge. Int. J. Gen. Med. 14, 3259–3270 (2021).
2. Swem, L. R. et al. A quorum-sensing antagonist targets membrane-bound and cytoplasmic receptors and controls bacterial pathogenicity. Mol. Cell. 35, 143–153 (2009).
3. Rutherford, S. T. & Bassler, B. L. Bacterial quorum sensing: Its role in virulence and possibilities for its control. Cold Spring Harb. Perspect. Med. 2, a012427 (2012).
4. Zhou, L., Zhang, Y., Ge, Y., Zhu, X. & Pan, J. Regulatory mechanisms and promising applications of quorum sensing-inhibiting agents in control of bacterial biofilm formation. Front. Microbiol. 11, 589640 (2020).
5. Venkatramanan, M. et al. Inhibition of quorum sensing and biofilm formation in Chromobacterium violaceum by fruit extracts of Passiflora edulis. ACS Omega 5, 25605–25616 (2020).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献